Healthtech PolaSight receives $100K investment at Constructor Start Demo Day
PolaSight, a spin‑off from the University of Bern, secured a $100,000 investment from Constructor Capital at the fourth Constructor Start Demo Day. The company has developed the PolaOne label‑free imaging device that uses polarized light and proprietary AI models to generate a live tissue map in under a minute, reducing intra‑operative tissue assessment time. PolaOne is currently a research‑use instrument and is being tested at the University of Bern’s Inselspital.
PolaSight, a spin‑off from the University of Bern, secured a $100,000 investment from Constructor Capital at the fourth Constructor Start Demo Day. The company has developed the PolaOne label‑free imaging device that uses polarized light and proprietary AI models to generate a live tissue map in under a minute, reducing intra‑operative tissue assessment time. PolaOne is currently a research‑use instrument and is being tested at the University of Bern’s Inselspital.
The investment supports a Swiss deep‑tech startup that leverages AI for medical imaging, illustrating Switzerland’s growing role in AI‑driven healthcare innovation.
Original source record. Open the original record to verify the underlying announcement.